Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been clinically diagnosed with papillary thyroid cancer
- People who have already had thyroid surgery (either open surgery or endoscopic/keyhole surgery)
- People aged between 18 and 90 years old
- People who speak Chinese
- People who are able to use a mobile phone and the internet to complete follow-up visits
- People who are willing to participate voluntarily and sign a consent form
Who may not be able to join:
- People whose hospital stay after surgery lasted more than 5 days
- People who are unable to complete online visits due to not having access to a device or the internet
- People considered at high risk of serious complications after surgery, such as damage to the nerve that controls the voice (confirm with trial site)
- People who are unable to participate due to other existing health conditions, abnormal lab test results, or a physical disability
- People who are pregnant
- People who have a mental illness or who take medications that affect mood or mental health, and were not able to undergo the surgery as a result
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86-19983137992
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The adherence to outpatient procedures
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.